Correction: Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications

Correction: Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications

Saved in:

Bibliographic Details
Main Authors:	Kai Yuan Leong, Seng Kong Tham, Chit Laa Poh
Format:	Article
Language:	English
Published:	BMC 2025-08-01
Series:	Virology Journal
Online Access:	https://doi.org/10.1186/s12985-025-02880-x
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications
by: Kai Yuan Leong, et al.
Published: (2025-03-01)

Revolutionizing mRNA Vaccines Through Innovative Formulation and Delivery Strategies
by: Munazza Fatima, et al.
Published: (2025-03-01)

The role of mRNA vaccines in infectious diseases: a new era of immunization
by: Kesaobaka Batisani
Published: (2025-05-01)

Comparing Moderna’s mRNA-1083 and Pfizer’s dual-target mRNA vaccines for influenza and COVID-19
by: Adewunmi Akingbola, et al.
Published: (2025-05-01)

Immune correlates analysis of mRNA-1345 RSV vaccine efficacy clinical trial
by: Chong Ma, et al.
Published: (2025-07-01)

Research progress of mRNA vaccines for infectious diseases
by: Zhen Zhang, et al.
Published: (2025-08-01)

mRNA-based vaccines for the prevention of coronavirus infection
by: S. M. Kharit, et al.
Published: (2022-04-01)

A Universal Strategy of Anti‐Tumor mRNA Vaccine by Harnessing “Off‐the‐Shelf” Immunity
by: Jiayan Fu, et al.
Published: (2025-02-01)

Harnessing mRNA vaccines for viral diseases: bottleneck and breakthrough
by: Vijay Mishra, et al.
Published: (2025-08-01)

Enhancing the potency of 5T4 mRNA vaccine by CD70 mRNA-LNPs through ADCC and T cell boosting in prostate cancer therapy
by: Fei Cao, et al.
Published: (2025-07-01)

Cost-effectiveness analysis of mRNA COVID-19 vaccine versus inactivated COVID-19 vaccine for mass vaccination in Jordan using a decision tree model
by: Qusai Abdulraheem AbuQamar, et al.
Published: (2025-08-01)

Immunogenicity and Protective Efficacy of an mRNA Vaccine Targeting HSV-2 UL41 in Mice
by: Tangwei Mou, et al.
Published: (2025-03-01)

mRNA mediates passive vaccination against infectious agents, toxins, and tumors
by: Moritz Thran, et al.
Published: (2017-08-01)

Optimizing mRNA Vaccine Degradation Prediction via Penalized Dropout Approaches
by: Hwai Ing Soon, et al.
Published: (2025-01-01)

mRNA vaccines and SiRNAs targeting cancer immunotherapy: challenges and opportunities
by: Zhen Lv, et al.
Published: (2025-07-01)

Immune and hematologicak responses to the third dose of an mRNA COVID-19 vaccine: a six-month longitudinal study
by: Waleed M. Bawazir, et al.
Published: (2025-07-01)

Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS‐CoV‐2 mRNA vaccination
by: Sebastian J Theobald, et al.
Published: (2022-07-01)

XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease
by: Simon Woelfel, et al.
Published: (2025-07-01)

A self-amplifying mRNA vaccine expressing PRV gD induces robust immunity against virulent mutants
by: Tong Ling, et al.
Published: (2025-08-01)

An mRNA vaccine provides effective protection against Duck Tembusu Virus infection
by: Shi Xu, et al.
Published: (2025-05-01)

Immunogenicity and safety of mRNA-based seasonal influenza vaccines encoding hemagglutinin and neuraminidase
by: Amanda K. Rudman Spergel, et al.
Published: (2025-07-01)

mRNA vaccine design using the proteome of Theileria annulata through immunoinformatics approaches
by: Roohollah Fattahi, et al.
Published: (2025-05-01)

mRNA COVID-19 vaccines induce superior immunoglobulin A titers in patients with cancer compared with viral vector vaccines: implications for immunization strategies
by: Yana Debie, et al.
Published: (2025-09-01)

Improved mRNA-based RSV vaccine with PreF forming enveloped virus-like particles
by: Pengdi Chai, et al.
Published: (2025-07-01)

Systemic mRNA aggregates elicit immunologic reprogramming that unlocks anti-cancer immunity
by: Hector R. Mendez-Gomez, et al.
Published: (2025-12-01)

COVID-19 mRNA vaccine immune response to the addition of osteopathic manipulative treatment with lymphatic pumps: a randomized controlled trial
by: Eric S. Martinez, et al.
Published: (2025-09-01)

A multivalent mRNA vaccine elicits robust immune responses and confers protection in a murine model of monkeypox virus infection
by: Yansheng Li, et al.
Published: (2025-08-01)

Unraveling the potential: mRNA therapeutics in oncology
by: Karol Gawalski, et al.
Published: (2025-08-01)

Quantifying the phenotypic information in mRNA abundance
by: Evan Maltz, et al.
Published: (2022-08-01)

Deconvolution of cargo delivery and immunogenicity following intranasal delivery of mRNA lipid nanoparticle vaccines
by: Mai N. Vu, et al.
Published: (2025-06-01)

Surveillance and follow up outcomes of myocarditis after mRNA COVID-19 vaccination in Australia
by: Lucy Deng, et al.
Published: (2025-07-01)

Divergent B-cell repertoire remodelling by mRNA, DNA and live attenuated vaccines in fish
by: Dean Porter, et al.
Published: (2025-07-01)

Correction: Whole mount multiplexed visualization of DNA, mRNA, and protein in plant-parasitic nematodes
by: Alexis L. Sperling, et al.
Published: (2025-07-01)

Target mRNA abundance dilutes microRNA and siRNA activity
by: Aaron Arvey, et al.
Published: (2010-04-01)

mRNA turnover rate limits siRNA and microRNA efficacy
by: Erik Larsson, et al.
Published: (2010-11-01)

New-Onset Palmar Psoriasis Following mRNA COVID-19 Vaccination: A Case Report
by: Alzamami HFA, et al.
Published: (2025-08-01)

The immunogenicity and protection efficacy evaluation of mRNA vaccine candidate for severe fever with thrombocytopenia syndrome in mice.
by: Da-Eun Jeong, et al.
Published: (2025-04-01)

Precision-engineered mRNA vaccines: antigen design, structural optimization, and programmable delivery for emerging pathogens
by: Yanyu Zhang, et al.
Published: (2025-08-01)

Decreased expression of inhibitory SMADs mRNA in keloid
by: YU Hai-yan, et al.
Published: (2006-01-01)

Circulating Antibodies Against Common Cold Coronaviruses Do Not Interfere with Immune Responses to Primary or Booster SARS-CoV-2 mRNA Vaccines
by: Bindu Adhikari, et al.
Published: (2025-05-01)